Last reviewed · How we verify
ACP-501
At a glance
| Generic name | ACP-501 |
|---|---|
| Sponsor | MedImmune LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)
- Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism (PHASE2)
- Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |